Rachel: How can the representation, how can this actually change? Is it something, do you think the National Institute of Health Research could step in and say that there must be a certain amount of women involved in trials or in the US also, the National Institute of Health?
Prof. Carolyn Young, Consultant Neurologist: Well, I don’t think that will be the answer, because that might slow down trial recruitment, because it doesn’t overcome any of the issues that we’ve just discussed. So, if the issue is that women are not able to access the same level of clinical care with the same frequency, with the same seniority of person in Centres of Excellence, which are trial centres, then we’ve got to correct that. That’s fundamental. Just putting some artificial later quota on would leave that problem unsolved.